The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Xarelto Tablets, 2.5 mg, 10 mg, ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA ...

In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

The US regulator has cleared 2.5mg tablet formulations of rivaroxaban – the active ingredient in Xarelto – from Sun Pharma subsidiary Taro Pharmaceuticals and Lupin, according to the Orange ...

Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic equivalents to name-brand rivaroxaban (Xarelto) ...

Rivaroxaban, an oral anticoagulant, helps prevent the formation of blood clots by inhibiting Factor Xa, an essential protein ...

Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood thinner ...

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...

Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rivaroxaban Tablets ...